Home » Topics » BioWorld Science

BioWorld Science
RSS

Prometheus Biosciences and Takeda collaborate to develop novel IBD therapies

Oct. 4, 2019

Healx collaborates with ICR to discover treatments for diffuse intrinsic pontine glioma

Oct. 4, 2019

Arbutus discontinues development of AB-506 following cases of acute hepatitis

Oct. 4, 2019

FDA approves Descovy for HIV-1 PrEP

Oct. 4, 2019

Liver-targeted uncouplers reverse type 2 diabetes, fatty liver in primates

Oct. 4, 2019

PARAGON-HF results for sacubitril/valsartan in heart failure with preserved ejection fraction

Oct. 4, 2019

Free fatty acid receptor 4 agonists disclosed by Axxam

Oct. 4, 2019

Voronoi patents EGFR/JAK3 inhibitors

Oct. 4, 2019

Ethris and Munster University Hospital receive support for work in primary ciliary dyskinesia

Oct. 4, 2019

New arginase inhibitors identified at Merck & Co.

Oct. 4, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...